Oncology

Afatinib Dimaleate

Irreversible pan-HER inhibitor for EGFR-mutant NSCLC

About Afatinib Dimaleate

Afatinib Dimaleate is an active pharmaceutical ingredient (API) classified under the Oncology category. Irreversible pan-HER inhibitor for EGFR-mutant NSCLC

Medical Use

Irreversible pan-HER inhibitor for EGFR-mutant NSCLC

Find Manufacturers in India

Pharmazon connects you with verified, GMP-certified pharmaceutical manufacturers who use Afatinib Dimaleate in their formulations. Browse verified suppliers, compare product catalogs, and request quotes directly.

Find Afatinib Dimaleate Manufacturers